Giskit Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for GISKIT, and when can generic versions of GISKIT drugs launch?
GISKIT has one approved drug.
There are three US patents protecting GISKIT drugs.
There are four patent family members on GISKIT drugs in six countries.
Drugs and US Patents for Giskit
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Giskit | EXEM FOAM KIT | air polymer-type a | FOAM;INTRAUTERINE | 212279-001 | Nov 7, 2019 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
Giskit | EXEM FOAM KIT | air polymer-type a | FOAM;INTRAUTERINE | 212279-001 | Nov 7, 2019 | RX | Yes | Yes | 9,849,199 | See Plans and Pricing | Y | See Plans and Pricing | |||
Giskit | EXEM FOAM KIT | air polymer-type a | FOAM;INTRAUTERINE | 212279-001 | Nov 7, 2019 | RX | Yes | Yes | 9,259,494 | See Plans and Pricing | Y | See Plans and Pricing | |||
Giskit | EXEM FOAM KIT | air polymer-type a | FOAM;INTRAUTERINE | 212279-001 | Nov 7, 2019 | RX | Yes | Yes | 9,034,300 | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Giskit Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Spain | 2529564 | See Plans and Pricing |
Poland | 2488211 | See Plans and Pricing |
European Patent Office | 2488211 | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2011046437 | See Plans and Pricing |
Netherlands | 2003660 | See Plans and Pricing |
Denmark | 2488211 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.